Koichiro Watanabe, MD, PhD
- 7Articles
- 24.3KReads
- 2008–2014Active
- 22Collaborators
- 62Citations
About
Koichiro Watanabe, MD, PhD, has authored multiple articles between 2008 and 2014 focusing on schizophrenia and schizoaffective disorders, particularly examining antipsychotic treatment effects such as dopamine D2 receptor occupancy with risperidone and olanzapine. The research also covers movement disorders related to antipsychotic use, including tardive dyskinesia, as well as sexual dysfunction and patient care challenges in psychiatric practice. Watanabe has collaborated frequently with Takefumi Suzuki, Hiroyuki Uchida, Haruo Kashima, Hiroyoshi Takeuchi, and Masaru Mimura.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
